TOLREMO therapeutics’ Post

If there were a piece of advice that CU Cancer Center member Rui Zhao, PhD, would give to an inspiring young person it would be: “If you can find a career doing what you love, that's the luckiest thing in your life, because you don't have to work a single day.” Learn about Zhao's career path and her lab's recent research into cancer biology here: https://lnkd.in/gX3_sePv #AAPIHeritageMonth #AAPI #Oncology #Biology

Fully Funded PhD Position in New therapies for blocking cancer metastasis In this doctoral project, the doctoral student will dissect BACH1 pro-metastatic activities in vitro by testing the BACH1- dependent invasive properties in a panel of metastatic human and mouse cell models. NGS sequencing and metabolomic tracing will be used to define the transcriptomic, epigenetic and metabolic landscape to investigate BACH1 pro-metastatic activities. The project will also include characterization and defining the adjuvant therapy potential of several newly identified BACH1 inhibitors in multiple state-of-the-art mouse models for metastatic tumors. Apply here: https://lnkd.in/eqQZbU3Z #phd #opportunities #phdposition #fundedPhD #FullyFundedPhD #research #university #openings #scholarship #AcademicTwitter #research #researchJobs #ResearchTweet

Fully Funded PhD Position in New therapies for blocking cancer metastasis In this doctoral project, the doctoral student will dissect BACH1 pro-metastatic activities in vitro by testing the BACH1- dependent invasive properties in a panel of metastatic human and mouse cell models. NGS sequencing and metabolomic tracing will be used to define the transcriptomic, epigenetic and metabolic landscape to investigate BACH1 pro-metastatic activities. The project will also include characterization and defining the adjuvant therapy potential of several newly identified BACH1 inhibitors in multiple state-of-the-art mouse models for metastatic tumors. Apply here: https://lnkd.in/eqQZbU3Z #phd #opportunities #phdposition #fundedPhD #FullyFundedPhD #research #university #openings #scholarship #AcademicTwitter #research #researchJobs #ResearchTweet

As we continue with Women's History Month, we would like to celebrate the work of Dr. Ann Tsukamoto. Dr. Tsukamoto was a pioneer in stem cell research who co-patented a groundbreaking process in 1991 that revolutionized the field. Her research focused on isolating human stem cells, which holds immense potential for treating various diseases, including cancer. These stem cells, often referred to as the body's "master cells," have the ability to differentiate into different types of cells and regenerate damaged tissue. Dr. Tsukamoto's work deepened our understanding of cancer patients' circulatory systems by isolating stem cells. She emphasized the importance of stem cells in finding cures for cancer and treating other illnesses. Her work extended to isolating liver and neural stem cells, which have impacted various diseases. Despite facing challenges initially to get her work recognized, Dr. Tsukamoto's persistence paved the way for future breakthroughs in stem cell research. Today, her legacy lives on as we continue to explore the immense potential of stem cells. Thank you, Dr. Ann Tsukamoto, for your incredible contribution to science and humanity! #womenshistorymonth #stemcells #research #WomenInScience #ScientificInnovation #HealthcareHeroes

An impressive fifty-five Peter MacCallum Cancer Centre researchers have been named in the top two per cent of most-cited scientists in the world based on a recently updated study published by Stanford University.   The top two per cent includes the top 100,000 most cited scientists as determined by a composite citation score, or “c-score”, focusing on the impact of citations rather than productivity (number of publications). The large number of Peter Mac researchers on the list illustrates our top-tier research status and positions our researchers in the highest impact rank in their research community. https://lnkd.in/gHVUscFQ

#QuestionForGroup Seeking Cancer Research Collaborators in USA/UK. As an AI researcher, I'm looking for partners in the USA or UK focused on cancer research, leveraging AI techniques, or exploring the intersection of both domains. If you or someone you know is working on ground-breaking cancer research, AI solutions for oncology, or applying AI to cancer diagnosis/treatment/drug discovery, I'd be honoured to connect. Potential collaborations include joint grant proposals, research projects, or initiatives combining AI and cancer research. My expertise lies in AI & healthcare (+ imaging/vision). Please reach out if interested in collaborating to advance cancer research and treatment through AI. Committed to this cause. Thanks a lot indeed. #cancer #ai #ml #atiqahad #uel #CancerResearch #CollaborationWanted #Oncology #HealthcareInnovation Ahad VISION Lab (AI & ML: Vision2Future) University of East London UEL School of Architecture, Computing and Engineering Cancer Research UK (CRUK) American Cancer Society NCI Center for Cancer Research Cancer Research UK Technology Team

Today, we turn our attention to Ann Tsukamoto for #womenhistorymonth, who is indeed a remarkable figure in the field of stem cell research. Through her extensive research and knowledge, Ann has made substantial contributions to the understanding and application of stem cells, particularly in the context of blood-forming stem cells. One of Tsukamoto's most significant achievements is her work in isolating blood-forming stem cells. This breakthrough has had profound implications for both basic science and medical applications. Understanding blood-forming stem cells is crucial for advancements in treating various diseases, including cancer. Tsukamoto's research has provided valuable insights into the circulatory systems of cancer patients. By elucidating the mechanisms underlying the formation and function of blood cells, her work has helped to develop new approaches to cancer treatment. These insights have contributed to the development of innovative therapies aimed at targeting cancerous cells while preserving healthy tissues. Throughout her career, Tsukamoto has been committed to advancing scientific knowledge in the field of stem cell research. Her dedication to publishing her findings has not only expanded our understanding of stem cells but has also inspired further research in this area. Overall, Ann Tsukamoto's pioneering work in stem cell research has had a profound impact on the scientific community and holds great promise for the future of medicine. #womenhistorymonth #womenpower #womenempowerment

Gerta Hoxhaj receives a 2024 Vilcek Prize for Creative Promise in Biomedical Science. An alum of Boğaziçi University, Hoxhaj completed her PhD at the University of Dundee, before moving to the United States to pursue postdoctoral research work on cancer metabolism at Harvard University. Hoxhaj is an Associate Professor at the Children's Medical Center Research Institute at the UT Southwestern Medical Center. She receives the $50,000 prize for her work on mapping the molecular links between signaling pathways and metabolic networks of cancer cells. Her research focuses on identifying vulnerabilities in cancer metabolism that could be used to develop targeted therapies. #CancerResearch #CancerScience #WomeninScience #WomeninSTEM #VilcekPrize

Many may not realise that quantum computing can help us find better cancer drugs. But this team of brilliant researchers from the University of Toronto, Insilico Medicine, and Zapata AI is tackling the seemingly impossible task of targeting KRAS-mutant cancer genes—long considered "undruggable." Using a hybrid quantum-classical algorithm, they generated a novel molecule designed to inhibit these stubborn genes. From this advanced computational effort, they filtered down to 15 promising molecules. Synthesising and testing them, guided by Dr. Igor Stagljar, they showcased the immense potential of combining quantum and classical computing. The experts, Yudong Cao and Dr. Alán Aspuru-Guzik praised the project, saying they could see a future where this method could transform cancer treatment and more. If this will be a success, I, too, am excited for the future of healthcare innovation. #QuantumComputing #CancerResearch

As 2023 comes to a close, there is a lot to commemorate and reflect on -- from advancing drug discovery to inspiring the next generation of scientists, to taking stem cell research to new heights (literally). Read more about our biggest milestones of 2023 and why we are excited for 2024: https://lnkd.in/eqf9qzN8